Financial statements Miropharm

Balance sheet of Miropharm

Company age:
Age:
14 y. 8 m.
Share capital:
Share capital:
5 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of MIROPHARM

Year
2020
2021
2022
2023
Total assets 2 209 292,58 2 820 106,06 3 330 173,49 3 257 745,15
A. Fixed assets 496 453,13 782 049,93 952 889,59 899 592,84
B. Current assets 1 712 839,45 2 038 056,13 2 377 283,90 2 358 152,31
C. Share capital contributions (basic funds) - - - -
D. Own shares (stocks) - - - -
Total liabilities 2 209 292,58 2 820 106,06 3 330 173,49 3 257 745,15
A. Equity -316 628,33 50 761,90 143 312,19 313 332,17
B. Liabilities and provisions for liabilities 2 525 920,91 2 769 344,16 3 186 861,30 2 944 412,98
I. Long-term liabilities - - - -
II. Short-term liabilities 2 525 920,91 2 709 344,16 3 166 861,30 2 864 412,98
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.